Increase in short telomeres during the third trimester in human placenta.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 01 03 2022
accepted: 29 06 2022
entrez: 13 7 2022
pubmed: 14 7 2022
medline: 16 7 2022
Statut: epublish

Résumé

An increase in telomere shortening in gestational tissues has been proposed as a mechanism involved in the timing for the initiation of parturition. An increase in very short telomeres with increasing gestational age has been observed in mice; this study sought to explore this phenomenon in human pregnancies. Specifically, this study addressed the hypothesis that prior to labor, the quantity of very short telomeres (<3 kilobase (kb) lengths) increases in human placental tissue as term gestation approaches. The primary outcome was the quantity of very short telomeres present in placental tissue. Quantitative measurements of very short telomeres were performed using real-time polymerase chain reaction (qPCR) adaptation of the telomere restriction fragment technique. Placental tissue from 69 pregnant individuals were included. Mean gestational age was 39.1 weeks (term) and 36.2 weeks (preterm). For term versus preterm placentas, the observed increase in very short telomeres were as follows: 500 bp telomeres increased by 1.67-fold (p < 0.03); 1 kb telomeres increased 1.67-fold (p < 0.08); and 3 kb telomeres increased 5.20-fold (p < 0.001). This study confirms a significant increase in very short telomeres in human placental tissue at term; thereby supporting the hypothesis that telomere shortening at term contributes to the mechanism that determine the length of pregnancy thereby leading to onset of parturition.

Identifiants

pubmed: 35830448
doi: 10.1371/journal.pone.0271415
pii: PONE-D-22-06161
pmc: PMC9278733
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0271415

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL146963
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cell Rep. 2012 Oct 25;2(4):732-7
pubmed: 23022483
Placenta. 2014 Oct;35(10):791-6
pubmed: 25096951
PLoS One. 2018 Dec 11;13(12):e0208533
pubmed: 30533028
Placenta. 2016 Aug;44:1-5
pubmed: 27452431
Am J Obstet Gynecol. 2017 Mar;216(3):294.e1-294.e8
pubmed: 27865975
Am J Obstet Gynecol. 2015 Feb;212(2):205.e1-8
pubmed: 25173189
Science. 2015 Dec 4;350(6265):1193-8
pubmed: 26785477
Placenta. 2016 Dec;48:26-33
pubmed: 27871469
JAMA Pediatr. 2017 Dec 1;171(12):1160-1167
pubmed: 29049509
Mol Biotechnol. 2004 Jun;27(2):169-72
pubmed: 15208457
Sci Rep. 2021 Mar 4;11(1):5115
pubmed: 33664422
Environ Int. 2015 Jun;79:1-7
pubmed: 25756235
Am J Obstet Gynecol. 2022 Apr 20;:
pubmed: 35460626
Early Hum Dev. 2010 Jul;86(7):451-6
pubmed: 20619976
Obstet Gynecol Sci. 2019 Jul;62(4):199-211
pubmed: 31338337
PLoS One. 2013;8(1):e54013
pubmed: 23326560
Pediatr Res. 2002 Sep;52(3):377-81
pubmed: 12193671
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
J Transl Med. 2018 Sep 12;16(1):254
pubmed: 30208911
Am J Reprod Immunol. 2017 May;77(5):
pubmed: 28185343
Cell. 2001 Oct 5;107(1):67-77
pubmed: 11595186
Reprod Sci. 2015 Oct;22(10):1186-201
pubmed: 26134037
Placenta. 2009 Jun;30(6):539-42
pubmed: 19359039
Am J Obstet Gynecol. 2019 May;220(5):496.e1-496.e8
pubmed: 30690015

Auteurs

Paula K Edelson (PK)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Michala R Sawyer (MR)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Kathryn J Gray (KJ)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

David E Cantonwine (DE)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

Thomas F McElrath (TF)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

Mark Phillippe (M)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH